Please provide your email address to receive an email when new articles are posted on . Patients younger than 40 years with non-presbyopic hyperopia had good visual outcomes after refractive lens ...

More than three million cataract surgeries performed in Europe annually[1] Basel, Switzerland, June 16, 2015 - Alcon, the global leader in eye care and a division of Novartis, has received European CE ...

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...

Intraocular lenses (IOL) used in modern cataract surgery have been designed to achieve a good quality of vision at near and intermediate distance as well as far. The FineVision® trifocal diffractive ...

Please provide your email address to receive an email when new articles are posted on . FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Pavel Stodulka, MD, PhD, ...

HONOLULU, Sept. 9, 2019 /PRNewswire/ -- Ophthalmological surgeons Tyrie Jenkins, M.D. and Jeffrey Peterson, M.D., Ph.D., of Jenkins Eye Care, now offer cataract ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American ...

Jeffrey Horn, MD, of Nashville, Tenn.-based Vision for Life, will implant a PanOptix Trifocal Intraocular Lens in a patient Sept. 4. 1. Dr. Horn will complete what is believed to be the first ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients ...

The FineVision trifocal diffractive IOL has three focal points for far, near and intermediate vision. This study examines the outcome of bilateral implantation of this IOL and provides far, ...

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...